Regenicin, Inc. (RGIN)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Sep 29, 2026
Regenicin Company Description
Regenicin, Inc., a biotechnology company, develops regenerative cell therapies to restore the health of damaged tissues and organs.
Its product includes Tiscela, a tissue-engineered skin graft that utilizes a patient’s own skin cells to create living, regenerative skin for treating severe burns and chronic wounds.
The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010.
Regenicin, Inc. was incorporated in 2007 and is headquartered in Las Vegas, Nevada.
Regenicin, Inc.
| Country | United States |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Randall McCoy |
Contact Details
Address: 3273 East Warm Springs Road Las Vegas, Nevada 89120 United States | |
| Phone | 800 211 6348 |
| Website | regenicin.com |
Stock Details
| Ticker Symbol | RGIN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| ISIN Number | US75887Q1022 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Randall E. McCoy | Chairman, Chief Executive Officer and President |
| John J. Weber | Chief Financial Officer and Director |
| Dr. J. Roy Nelson Ph.D. | Controller and Chief Science Officer |